Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT04747236
Title A Randomized, Phase IIB, Multicenter, Trial of Oral Azacytidine Plus Romidepsin Versus Investigator's Choice in Patients With Relapse or Refractory Peripheral T-cell Lymphoma (PTCL)
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors University of Virginia

peripheral T-cell lymphoma

cutaneous T cell lymphoma

breast implant-associated anaplastic large cell lymphoma

nasal type extranodal NK/T-cell lymphoma

adult T-cell leukemia

angioimmunoblastic T-cell lymphoma

anaplastic large cell lymphoma

mycosis fungoides




Azacitidine + Romidepsin



Age Groups: senior | adult
Covered Countries USA

Facility Status City State Zip Country Details
University of Virginia Recruiting Charlottesville Virginia 22911 United States Details
*Shaded cells indicate that there was no data available from for the field